## Clinical Scenario Analysis This patient presents with **preterm labor at 30 weeks** (viable gestational age) with regular contractions, cervical change, and intact membranes—meeting diagnostic criteria for preterm labor. ## Management Principles at 30 Weeks **Key Point:** Between 24–34 weeks, the standard of care is **tocolysis + corticosteroids + transfer to tertiary center** to optimize neonatal outcomes. ### Rationale for Each Component | Intervention | Indication at 30 weeks | Benefit | |---|---|---| | **Corticosteroids** | Accelerate fetal lung maturity | Reduces RDS by 60%, IVH, NEC | | **Tocolytics** | Delay delivery 48 hours minimum | Allows steroid effect, in-utero transfer | | **Tertiary transfer** | Neonatal intensive care availability | Improves survival and reduces morbidity | | **Magnesium sulfate** | Given *only* if delivery imminent (< 32 weeks) | Neuroprotection; not first-line tocolytic | **High-Yield:** Nifedipine (calcium channel blocker) is preferred tocolytic in India and most guidelines due to safety profile and efficacy. Indomethacin is avoided after 32 weeks (risk of PDA closure). ## Why NOT Magnesium Sulfate First? **Clinical Pearl:** Magnesium sulfate is **neuroprotective** (reduces cerebral palsy risk) when delivery is anticipated *within 24–32 weeks*, but it is **not a tocolytic**. Using it alone without tocolytics will not arrest labor. ## Why NOT Fetal Fibronectin? **Warning:** fFN testing has high **negative predictive value** (rules out preterm labor if negative) but is **not indicated once preterm labor is diagnosed clinically**. Here, the diagnosis is already confirmed by cervical change and contractions—fFN would delay essential therapy. ## Why NOT Expectant Management? At 30 weeks with documented cervical dilation and regular contractions, bed rest alone is insufficient and delays life-saving interventions (steroids, tocolytics, neonatal preparation).
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.